©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Expression and Functional Analysis of a Novel Isoform of Gicerin, an Immunoglobulin Superfamily Cell Adhesion Molecule (*)

(Received for publication, July 17, 1995; and in revised form, September 21, 1995)

Eiichi Taira (§) Tomoko Nagino Hideo Taniura Natsuki Takaha Cheol-Hee Kim Che-Hui Kuo Bing-Shen Li Hiroshi Higuchi Naomasa Miki

From the Department of Pharmacology 1, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565, Japan

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

We have cloned a novel cDNA of gicerin, a cell adhesion molecule belonging to the immunoglobulin superfamily. Both gicerin isoforms share the same extracellular domain, which has five immunoglobulin-like loop structures and a transmembrane domain as s-gicerin, but differ in the cytoplasmic tail domain. As the newly identified form has a larger cytoplasmic domain than the previously reported form, we refer to them as l-gicerin and s-gicerin, respectively. l-gicerin is transcribed from a distinct mRNA containing an inserted sequence not found in s-gicerin mRNA which caused a frameshift for the coding region for a cytoplasmic domain. Previous studies demonstrated that gicerin showed a doublet band of 82 and 90 kDa in chicken gizzard smooth muscle. We report that the 82-kDa protein corresponds to s-gicerin and the 90-kDa protein to l-gicerin. We also found that the two gicerin isoforms are expressed differentially in the developing nervous system. Functional analysis of these gicerin isoforms in stable transfectants revealed that they had differ in their homophilic adhesion properties, as well as in heterophilic cell adhesion assayed with neurite outgrowth factor. In addition, these isoforms have neurite-promoting activity by their homophilic adhesion, but differ in their ability to promote neurite outgrowth.


INTRODUCTION

Cell adhesion molecules are widely expressed in the nervous system and play a crucial role in the organization of neural networks during development(1, 2) . Members of the immunoglobulin (Ig) superfamily are homophilic cell adhesion molecules, expressed in the nervous systems of a variety of animal species (3, 4, 5) that participate in neurite extension, fasciculation of nerve fibers, and neuronal migration (6, 7, 8, 9, 10) . Recent studies provide evidence that they are also involved in synaptic plasticity (11) and programmed cell death of neurons(12) . These findings underscore the importance of Ig superfamily molecules in cell-cell communication during nervous system development. Cell adhesion molecules of the Ig superfamily are divided into several subgroups. Members of one group have only Ig-like domains in their extracellular domains; the others form a subgroup that have fibronectin type III-related domains between Ig-like and transmembrane domains (13) . Members of the first group include fasciclin III(14) , neuromusculin(15) , and SC1/DM-GRASP/Ben (16, 17) that are mainly expressed in neurons, as well as MAG (^1)(3, 18) and SMP (19) that are found in glial cells. Ig superfamily molecules have also been classified into two groups by their mode of membrane association, with some containing a phosphatidylinositol anchor (20, 21) and others a transmembrane domain(8, 22) . Interestingly, some Ig superfamily members undergo alternative splicing to generate multiple forms that differ in the type of membrane association used(23, 24) . The alternatively spliced products are differently expressed spatially and temporally and expected to play different roles(4) . MAG, the molecule most homologous to gicerin, is known to have two isoforms that differ in the length of their cytoplasmic domains(3, 25) . These forms are differentially regulated during development with only l-MAG found to be associated with Fyn, a nonreceptor tyrosine kinase(26) .

Gicerin is a cell adhesion molecule with five Ig-like domains(27) . It was first identified as a binding protein for neurite outgrowth factor (NOF), a member of the laminin family(28, 29) . In the nervous system gicerin expression is transient, restricted to early stages of development when neurons extend neurites or undergo migration(30) , whereas constitutive expression is found in muscles and kidney. Introduction of gicerin into L929 fibroblast cells in vitro indicate that gicerin exhibits homophilic cell adhesion activity in addition the heterophilic adhesion to NOF(27) . In previous studies, we noted that Western blot analysis of endogenous gicerin in chicken gizzard reveals a doublet band, perhaps reflecting the presence of alternatively spliced products. In the present study, we identified and characterized a novel longer isoform of gicerin termed l-gicerin, which contains a different cytoplasmic tail than that found in the previously reported form of gicerin (s-gicerin (accession number D38559)). We have also investigated possible functional differences between these two gicerin isoforms and compared their expression during nervous system development.


MATERIALS AND METHODS

cDNA Cloning and Sequencing

A gt 11 chicken gizzard cDNA library (Clontech) was used for screening using the plaque hybridization method. A cDNA probe encoding gicerin (27) was prepared by the random primer labeling method with [P]dCTP, and screening was carried out with standard procedures(31) . Purified cDNA inserts were subcloned into a Bluescript II SK(-) phagemid vector (Stratagene), and the sequences were determined by the dideoxy chain termination method (32) using Sequenase (U. S. Biochemical Corp.). Both strands were fully sequenced by obtaining endonuclease-digested fragments.

RT-PCR and Southern Blot Analysis

Total RNA was isolated from chicken gizzard smooth muscle by the AGPC method (33) and a 1-µg aliquot was reverse-transcribed by murine leukemia virus reverse transcriptase (Life Technologies, Inc.). The products were then used for PCR templates with synthetic oligonucleotide primers which contained EcoRI restriction site: G-5`, TATAGAATTCTTGATTGGCAGCGGGCATGG; I-5`, TATAGAATTCAGATAAACTTTCCGAAGAGG; for 5` primers and G-3`, TATAGAATTCGTAAGCGAAGTCTGCTGCTGA and I-3`, TATAGAATTCCTCTTCGGAAAGTTTATCTGA; for 3` primers (I-5` and I-3` were complementary). The sequences between the two primers; G-5`/G-3`, G-5`/I-3`, and I-5`/G-3` were amplified by PCR using Taq DNA polymerase (Perkin-Elmer) using the following parameters: 96 °C for 1 min, 55 °C for 2 min, and 72 °C for 3 min for 30 cycles and then 72 °C for 7 min. PCR products amplified between G-5`/G-3` and G-5`/I-3` were digested with endonuclease SacI that recognized a single site in the products. These digested and undigested DNA fragments were separated by 2% agarose-gel electrophoresis and stained with ethidium bromide.

Generation of Anti-l-gicerin-specific Antibodies

Multiple antigen peptides (MAP) were generated by the Fmoc (N-(9-fluorenyl)methoxycarbonyl) strategy using MAP core molecule attached to PA-Resin (Novabiochem)(34, 35) . The synthetic peptides corresponded to residues 579-590 (TKPEARKDKNVV) (Peptide A) and residues 605-624 (QCANAEKRSPADQSEKYIDL) (Peptide B) that were l-gicerin-specific and located in the cytoplasmic tail. The products were purified through Sephadex G-25 (Pharmacia). After rabbits were immunized with a mixture of these two multiple antigen peptides, the sera were collected.

Protein Extraction

Cultured cells were harvested with a cell scraper after rinsing twice with Ca- and Mg-free Hanks' solution. The harvested cells or freshly dissected chicken tissues were homogenized in phosphate-buffered saline(-) with a Polytron homogenizer. The homogenates were centrifuged at 18,000 times g for 30 min, and the pellets were solubilized in 10 mM Tris acetate (pH 8.0), 1 mM EDTA, 0.5% Nonidet P-40. They were centrifuged at 40,000 times g for 90 min after incubating at 4 °C on a rotating shaker for 1 h, and the resultant supernatants were used for Western blot analysis(27) .

Immunoprecipitation, Deglycosylation, and Western Blot Analysis

The supernatant fraction obtained after Nonidet P-40 extraction was preadsorbed with protein A (Pharmacia), incubated with each antiserum, and then immunoprecipitated with protein A-Sepharose. Heat-denatured supernatant was processed for Western blot analysis. To examine the effect of deglycosylation, the Nonidet P-40-extracted fraction was digested with N-glycosidase F (Boehringer Mannheim) overnight. Proteins were separated by 7.5% SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Bio-Rad). The blots were incubated with primary antiserum after blocking with 2% skim milk. Then the blots were incubated with horseradish peroxidase-conjugated secondary antibodies and developed with diaminobenzidine.

Construction of Expression Vectors and Establishment of Gicerin-expressing Cell Lines

A cDNA encoding l-gicerin (lG) was subcloned into pcDNA1 (Invitrogen) to construct the expression vector pcDNA1-lG. For establishing cell lines that express l-gicerin, mouse fibroblast L929 cells were transfected with both pcDNA1-lG and the neomycin resistance vector pMAM-neo (Clontech), using Lipofectin (Life Technologies, Inc.) (10:1). G418-resistant clones were isolated after being cultured for 2 weeks in the presence of 0.6 mg/ml of G418 (Life Technologies, Inc.) and examined by immunocytochemistry and Western blot analysis with anti-gicerin antisera. L929 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% FCS and the following antibiotics and antimycotics: 100 units/ml penicillin, 100 mg/ml streptomycin, and 250 ng/ml amphotericin B (Life Technologies, Inc.). Several gicerin-positive cell lines (l-lGs) were obtained and employed for further experiments. s-Gicerin expressing L929 cell lines (27) were renamed l-sGs. All these established cell lines were grown in the same medium containing 0.1 mg/ml G418.

Cell Aggregation Assay

Cell aggregation experiments were carried out as reported previously(27, 36) . Cell suspensions (2 times 10^6 cells/ml) were prepared from each subconfluent monolayer. In some experiments, antibodies were added at a final concentration of 0.2 mg/ml and kept on ice for 30 min before starting the aggregation assay. The assay was carried out by incubating the cell suspension at 37 °C in a CO(2) incubator without agitation. A small aliquot was withdrawn every 15 min after gentle mixing, and the particles were counted in a hemocytometer. The degree of cell aggregation was estimated by the index N(t)/N(0) according to conventional methods(17, 37) . The index N(0) was the total particle number at the initial incubation time (0 min), and the index N(t) was the total particle number at the incubation time t. Experiments were performed four times and the scores averaged. Photographs were taken of cells in suspension after 1 h of incubation.

Neurite Extension of Ciliary Ganglion Cells on the Feeder Layer of Gicerin Transfectants

Ciliary ganglions (CGs) were dissected from the 8-day chick embryo. They were treated with 0.05% trypsin and 0.53 mM EDTA for 20 min at room temperature, then resuspended in Dulbecco's modified Eagle's medium containing 10% FCS and dissociated by gentle pipetting. Resultant single cells were preincubated on a plastic dish for 1 h to let non-neuronal cells attach to the dish(29, 38) . The nonattached ciliary ganglion neurons were plated on feeder layers of confluent gicerin transfectants or parental L929 cells grown in 30-mm dishes (500 CG cells/dish) and co-incubated for 24 h(39) . The cultures were fixed with Zamboni's solution, and the CG neurons were detected by immunocytochemistry with anti-MAP2 antibodies(40) . The relative length of the neurites from the MAP2-positive cells were judged under microscopy, and the same experiments were performed at least three times. In some experiments, anti-gicerin polyclonal antibodies were added both to the preincubated CG cells and the feeder cells 1 h before starting the co-culture, and anti-MAP2 monoclonal antibodies were employed for detection of neurons with neurites.

Cell Adhesion Assays

Cell adhesion experiments were carried out as reported previously(27) . Four-ml aliquots of each test sample containing 10 ng/ml of purified NOF (28) were spotted on a 35-mm test dish coated with nitrocellulose and incubated for 1 h in a humidified CO(2) incubator at 37 °C. The dishes were washed with Dulbecco's modified Eagle's medium containing 10% FCS three times and preincubated with the medium containing 10% FCS for 1 h to block nonspecific binding. Two-ml aliquots of the cell suspension (2 times 10^6 cells/ml) were plated on the test dishes. To assess the inhibition of adhesion activity by antibodies against gicerin, the cells were preincubated with the antibodies at a final concentration of 0.2 mg/ml on ice for 30 min before plating on the test dishes. The dishes were kept in CO(2) at 37 °C for 30 min, then washed twice with Hanks' solution containing Ca and Mg and fixed with Zamboni's solution. Adhesion to the dishes was then assessed by phase-contrast microscopy.


RESULTS

Molecular Cloning of a Novel Isoform of Gicerin

An s-gicerin cDNA clone was used to prepare a probe for screening a gt 11 chicken gizzard library. We obtained seven independent positive clones and determined their sequences, after subcloning into phagemid Bluescript II SK(-). We obtained cDNA clones that encoded sequences that differed from that reported for s-gicerin and rescreened the same library to obtain four clones that encoded a novel protein. We found that the novel l-gicerin cDNA (EMBL/DDBJ/GSDB/NCBI accession number D49849) had a 121-bp insert in the cytoplasmic domain that encoded 63 amino acid residues and produced a frameshift to form a larger tail with a distinct sequence ( Fig. 1and 2). The cytoplasmic domain of l-gicerin showed no significant homology with known molecules. Analysis of the extracellular domain did not reveal any difference between these gicerin isoforms.


Figure 1: DNA and deduced amino acid sequences of l-gicerin. Cysteine residues are marked with asterisks, and the single transmembrane domain is underlined. Sequences employed for RT-PCR primers and the SacI consensus sequence are underlined by thinner bars. The primer names are indicated above the sequences.



Characterization of Gicerin Isoform mRNAs

To confirm the existence of two distinct gicerin mRNA species, total RNA was extracted from chicken gizzard smooth muscle and analyzed by reverse transcription-PCR (Fig. 3A). As expected, two sizes of RT-PCR products were detected when the G-5` and G-3` primers that span the insert were used. Furthermore, only one product was amplified when the I-3` primer, based on the insert sequence, was used instead of G-3`. We also obtained a single product when the 5` primer I-5`, based on a segment of the insert, was used with G-3`. Digestion of these PCR products with SacI, which has one site conserved in both isoforms (underlined in Fig. 1), generated products with the expected sizes (Fig. 3B).


Figure 3: Expression of s-gicerin and l-gicerin RNA transcripts in chicken gizzard smooth muscle. A, cDNA structures of each gicerin and the location of primers. An open box indicates the open reading frame, a black box the transmembrane domain, and the striped box the l-gicerin-specific insert. Locations of each primer are indicated. B, gel electrophoresis of RT-PCR products. Total RNA was amplified by RT-PCR with both gicerin and l-gicerin-specific primers. An aliquot of the products was digested by restriction endonuclease SacI, and the products were electrophoresed in a 2% agarose gel and stained with ethidium bromide. Lane M, size marker; lane 1, G-5`/G-3` primer set which amplify both l- and s-gicerin (2083 and 1963 bp each); lane 2, G-5`/I-3` primer set which amplify only l-gicerin (1837 bp); lane 3, I-5`/G-3` primer set which amplify only l-gicerin (288 bp); lane 4, products in lane 1 were digested by SacI (1629, 1509, and 454 bp); lane 5, product in lane 2 was digested by SacI (1383 and 454 bp).



Identification of l-gicerin by Western Blot Analysis

To produce an antiserum specific for l-gicerin, we utilized two multiple antigenic peptides found in the cytoplasmic domain of l-gicerin but not s-gicerin (Fig. 2). Immunoprecipitation was carried out with anti-gicerin antibodies prepared previously or with antibodies prepared against the l-gicerin-specific peptides. To examine the selectivity of the anti-l-gicerin antisera, we first immunoprecipitated both gicerin isoforms from Nonidet P-40 gizzard extracts with anti-gicerin antibodies and then performed immunoblot analysis. Only the upper band of the doublet detected by the anti-gicerin antiserum was recognized by anti-l-gicerin antiserum (Fig. 4). Conversely, the upper band was detected by both antisera in Western blot analysis, when immunoprecipitation was performed with anti-l-gicerin antibodies. We performed immunoblot analysis following digestion of the Nonidet P-40 extracts of the gizzard with N-glycosidase F, since the predicted amino acid sequence of gicerin has eight potential N-linked glycosylation sites. The digested gicerins were detected as a doublet band of 70 and 64 kDa, and only the upper band of the doublet was recognized with anti-l-gicerin antiserum (Fig. 5). The predicted molecular masses of l- and s-gicerin were calculated to be 69.0 and 63.9 kDa, respectively, which matches that observed for the deglycosylated gicerins. These studies demonstrate that the l-gicerin transcript encodes the larger isoform of gicerin. Next, we compared the expression of gicerin isoforms in the nervous system by Western blot analysis with these two antisera. Previous studies revealed that gicerin was highly expressed in the embryonic retina, cerebellum, and optic tectum and thereafter levels gradually decrease during development. We found that s-gicerin was expressed in the retina, l-gicerin in the optic tectum, and both in the cerebellum (Fig. 6, A and B).


Figure 2: Comparison of cytoplasmic sequences of l-gicerin and s-gicerin. Amino acid sequences of cytoplasmic domains of both s-gicerin and l-gicerin are indicated with cDNA sequences. The numbers shown correspond to the amino acids indicated in Fig. 1. Amino acid residues employed for constructing multiple antigen peptides for generating l-gicerin-specific antiserum are shown in bold and underlined. The oligopeptide names are indicated above the sequences.




Figure 4: Immunoprecipitation analysis of chicken gizzard gicerin. The Nonidet P-40-extracted fraction of chicken gizzard and the immunoprecipitated samples were separated by 7.5% SDS-PAGE under reducing condition. Western blot analysis was performed with anti-gicerin antiserum (lanes 1-3) or with anti-l-gicerin-specific antiserum (lane 4-6) followed by horseradish peroxidase-conjugated secondary antibodies. Lane 1, Nonidet P-40-extracted fraction of gizzard; lane 2, immunoprecipitated with protein A-Sepharose loaded with anti-gicerin antibodies; lane 3, immunoprecipitated with protein A-Sepharose loaded with anti-l-gicerin-specific antibodies; lane 4, Nonidet P-40-extracted fraction of gizzard; lane 5, immunoprecipitated with protein A-Sepharose loaded with anti-gicerin antibodies; lane 6, immunoprecipitated with protein A-Sepharose loaded with anti-l-gicerin-specific antibodies.




Figure 5: Deglycosylation analysis of gizzard gicerin. Nonidet P-40-extracted fraction and the N-glycosidase F-digested samples were separated by 7.5% SDS-PAGE under reducing conditions. Western blot analysis was performed with anti-gicerin antiserum (lanes 1 and 2) or with anti-l-gicerin-specific antiserum (lanes 3 and 4) followed by horseradish peroxidase-conjugated secondary antibodies. Lane 1, Nonidet P-40-extracted fraction; lane 2, Nonidet P-40-extracted fraction digested by N-glycosidase F; lane 3, Nonidet P-40-extracted fraction; lane 4, Nonidet P-40-extracted fraction digested by N-glycosidase F.




Figure 6: Expression of gicerin in the nervous system. 20 µg of Nonidet P-40-extracted fraction from each tissue were separated by 7.5% SDS-PAGE under reducing conditions. Western blot analysis was performed with anti-gicerin antiserum (A) or with anti-l-gicerin-specific antiserum (B) followed by horseradish peroxidase-conjugated secondary antibodies. Lanes 1, gizzard; lanes 2, embryonic day 8 retina; lanes 3, embryonic day 18 retina; lanes 4, embryonic day 6 optic tectum; lanes 5, embryonic day 18 optic tectum; lanes 6, embryonic day 11 cerebellum; lane 7, embryonic day 18 cerebellum. The big band of about 53 kDa (B) is a degenerated product of that gicerin that was sometimes observed in repeatedly frozen samples.



Establishment of l-gicerin-expressing Cell Lines

The l-gicerin cDNA was subcloned into the mammalian expression vector pcDNA1 to construct pcDNA1-lG. The construct was co-transfected into the mouse fibroblast cell L929 with a neomycin resistance vector pMAM-neo, and cells were selected with G418. Cell lines were screened for high levels of l-gicerin expression by immunofluorescent cytochemistry and Western blot analysis with anti-gicerin antiserum. We chose three clones (l-lG-1, -3, and -5) for further experiments. While s-gicerin transfectants exhibited a single band of 86 kDa(27) , l-gicerin lines exhibited a doublet band of 92 and 84 kDa (Fig. 7A). Appearance of a lower band of l-gicerin might reflect proteolytic degraded fragments, since only the upper band was detectable by l-gicerin-specific antiserum, and the intensity of the upper band decreased as the lower band increased following prolonged storage (data not shown). Following digestion with N-glycosidase F, the molecular size of the recombinantly expressed proteins decreased to 64 kDa for s-gicerin and 70 and 66 kDa for l-gicerin. Only the upper band of l-gicerin transfectants was detected by anti-l-gicerin antiserum before and after N-glycosidase F digestion. The deglycosylated product of s-gicerin corresponded to the predicted molecular mass of 63.9 kDa (Fig. 7B). Only the upper band of the deglycosylated products from l-gicerin transfectants corresponded to the predicted mass of 69.0 kDa, while the lower band may be due to degradation after extraction.


Figure 7: Comparison of gicerin isoforms expressed in cell lines. Nonidet P-40-extracted fraction (A) and the N-glycosidase F-digested samples (B) were separated by 7.5% SDS-PAGE under reducing conditions. Western blot analysis was performed with anti-gicerin antiserum (lanes 1-3) or with anti-l-gicerin-specific antiserum (lanes 4-6) followed by horseradish peroxidase-conjugated secondary antibodies. A, Nonidet P-40 extracts; B, N-glycosidase F-digested samples; lanes 1 and 4, gizzard; lanes 2 and 5, s-gicerin transfectants; lanes 3 and 6, l-gicerin transfectants (l-lG-1 and l-lG-3, respectively).



Aggregation Activity of Cells Expressing Single Gicerin Isoform

In previous studies, we have shown that s-gicerin possesses homophilic cell aggregation activity. To investigate possible differences in the functional activities of s- and l-gicerin, we first compared their ability to mediate homophilic adhesion (Fig. 8). Analysis of multiple transfectants of both types revealed that cell lines expressing the same gicerin isoform exhibited nearly identical cell aggregation activity (Fig. 9). Previous studies of multiple s-gicerin transfectants revealed a similar pattern across cell lines(27) . Cell aggregation was inhibited by the addition of anti-gicerin antibodies, as shown previously. Comparison of the degree of cell aggregation activity revealed that s-gicerin transfectants aggregated more strongly than l-gicerin transfectants. These findings suggest that the cytoplasmic domain influences homophilic binding activity.


Figure 8: Aggregation patterns of parental L929 cells and stable s- or l-gicerin transfectants. Cells were dissociated by mild trypsinization and resuspended in the culture medium. They were incubated in a CO(2) incubator at 37 °C and photographed in suspension after 1 h. In some experiments, gicerin antibodies were added at a final concentration of 0.2 mg/ml and kept on ice for 30 min before starting the incubation. A, parental L929 cells; B, l-sG-1, stable transfectants of s-gicerin; C, l-lG-1, stable transfectants of l-gicerin; D, l-lG-1 pretreated with gicerin antibodies. Bar, 120 mm.




Figure 9: Aggregation pattern of gicerin transfectants. A, time course of aggregation of l-gicerin-stable transfectants, s-gicerin transfectants, and parental L929 cells. Cells (cell lines l-lG-1, -3, and -5) were mildly trypsinized and incubated at 37 °C. An aliquot of each sample was withdrawn every 15 min after gentle mixing, and the particle number was counted in a hemocytometer. The degree of cell aggregation was estimated by the index N/N(0)(see ``Experimental Procedures''). Each point represents an average of four independent experiments. In the experiments conducted in the presence of anti-gicerin antibodies, cells were preincubated with them 30 min before starting the aggregation time course. Results from parental L929 cells and s-gicerin transfectants are reported as the mean ± S.D. of the values measured for each of several cell lines (27) .



Neurite Extension from Ciliary Ganglion Cells Grown on a Layer of Gicerin Transfectants

We next examined the effect of gicerin on neurite outgrowth. As CG neurons of 8-day chick embryos express gicerin, these were co-cultured on a layer of the gicerin transfectants or parental L929 fibroblasts. We measured the relative length of neurites by MAP2 immunocytochemistry, and more than 1000 neurons per each clones were counted. We scored cells with neurite length longer than the cell body diameter as neurite-positive (Fig. 10). CG neurons showed little neurite extension when grown on the parental L929 cells for 24 h, but exhibited extensive outgrowth on s-gicerin transfectants (Fig. 11). Neurite extension was blocked by preincubating with anti-gicerin antibodies, indicating that neurite extension from embryonic CG neurons was mediated by gicerin. Compared with s-gicerin transfectants, l-gicerin was less active in promoting neurite extension. As l-gicerin was also less active in the homophilic adhesion assay, these findings provide additional evidence that the cytoplasmic domain play an integral role in gicerin's functional activity.


Figure 10: Neurite extension from embryonic CG neurons on a feeder layer of gicerin transfectants. Dissociated CG neurons from embryonic day 8 chick retina were cultured for 24 h on confluent monolayers of control L929 (A), l-sG-1 (B), and l-lG-1 (C) cells. The cultures were fixed and immunostained for MAP2. Bar, 25 mm.




Figure 11: Comparison of neurite extension. Dissociated CG neurons from embryonic day 8 chick retina were cultured for 24 h on confluent monolayers of control L929 or gicerin transfectants (l-sG-1 and -2 and l-lG-1 and -3). To asses inhibition of neurite extension by anti-gicerin antibodies, both the CG neurons and feeder cells were preincubated with antibodies 30 min before mixing the cultures. The cultures were fixed and immunostained with anti-MAP2 antibodies. Neurons with neurites longer than the cell body were scored as neurite positive. More than 1000 neurons were examined microscopically for each condition shown.



Cell Adhesion Activity of Gicerin Transfectants

We have demonstrated previously that s-gicerin transfectants adhere to NOF in a specific fashion. In comparing the ability of s- and l-gicerin transfectants to NOF, we found that s-gicerin transfectants show stronger adhesive activity than l-gicerin transfectants (Fig. 12). This adhesion activity was blocked by pretreating with anti-gicerin antibodies. Thus, alterations in gicerin's cytoplasmic tail also influence its NOF binding activity.


Figure 12: NOF adhesion activity. Purified NOF or control laminin was spotted on nitrocellulose-coated dishes. Only the right half of each field is coated with NOF or laminin. Adhesion of each gicerin transfectant to the dish was examined by phase-contrast microscopy. Adhesion of l-sG-1 (A) and l-lG-1 (C) was blocked by preincubating with anti-gicerin antibodies: l-sG-1 (B) and l-lG-1 (D). No adhesion of l-lG-1 to laminin (E) or parental L929 to NOF (F) was observed. The same results were obtained with other transfectants. Bar, 120 mm.




DISCUSSION

In the present paper, we isolated a novel isoform of gicerin (l-gicerin) that differs from the previously reported isoform s-gicerin in the cytoplasmic tail domain. Comparison of the functional activity of these isoforms revealed that l-gicerin was not as effective as s-gicerin in assays of both homophilic and heterophilic adhesion. These findings indicate that the cytoplasmic domain is not merely a passive structural feature but exerts an important influence on the adhesive properties of the extracellular domain.

Gicerin was originally purified from chicken gizzard as a doublet with molecular sizes of 82 and 90 kDa(29) . Recently, we have reported the molecular cloning and functional analysis of gicerin, which we renamed s-gicerin here(27) . However, these studies did not clarify the origin of the doublet band. Since gicerin mRNA from gizzard exhibited a broad single band of about 5.2 kilobases, we considered two likely possibilities: 1) the two bands on SDS-PAGE reflect different post-transcriptional modification such as glycosylation or 2) they were translated from different mRNA species with similar size.

Following digestion of gizzard membrane extracts with N-glycosidase F, two bands migrating as 70 and 64 kDa proteins were detected by Western blot analysis. The predicted molecular mass of s-gicerin was 63.9 kDa, matching the size of the smaller digested product. The presence of the 70-kDa gicerin immunoreactive band favored the existence of two different gicerin proteins. Of note, precedent for this alternative is provided by MAG, a homologous molecule that has two isoforms detected as a doublet band on Western blot analysis(3, 18) . To pursue this possibility, we screened for a novel gicerin isoform and isolated a cDNA clone that encoded a larger isoform of gicerin (l-gicerin) which differed from s-gicerin only in the cytoplasmic coding region. The predicted molecular mass was calculated to be 69.0 kDa, corresponding to the larger band (70 kDa) seen following N-glycosidase F digestion. We also confirmed the existence of two different mRNAs by RT-PCR analysis. The expected size products were obtained and confirmed by restriction analysis (Fig. 3B) and sequencing both ends of the products. Southern blot analysis indicated the presence of only a single gicerin gene in the genome (data not shown). We, therefore, concluded that these two mRNA species were generated by alternative splicing.

We then examined whether the doublet band detected with SDS-PAGE originates from these two mRNA species, as expected. An antiserum specific for l-gicerin was produced and reacted with only the upper 90-kDa band of the doublet seen in gizzard extracts and the upper 70-kDa band following N-glycosidase F treatment. These two molecules did not co-precipitated when immunoprecipitated with l-gicerin-specific antiserum, even under mild condition in the presence of 0.5% Nonidet P-40, suggesting that they do not form a tight dimer.

The distribution of both subtypes was examined in the developing nervous system by Western blot analysis. In the retina, only s-gicerin was detected. In contrast, only l-gicerin was found in the optic tectum. Both gicerins were expressed in the cerebellum. Differential expression among cell types may help account for different responses to NOF and gicerin seen in these regions. We have reported that neurons in cultured retinal explants that express s-gicerin selectively extend neurites in response to NOF(29) , while the cerebellar explants cultured on NOF display migration of neurons (probably granular cells) in addition to neurite extension(30) .

To examine functional differences between these two gicerin isoforms, we established cell lines expressing each alone. Although the degree of l-gicerin expression differed a little among three cell lines tested, similar cell aggregation activities were observed among the l-gicerin transfectants. Presumably, the amount of gicerin expressed was over a threshold amount needed to achieve a maximal cell adhesion activity. A similar result was obtained in previous experiments examining s-gicerin transfectants(27) . Experiments investigating NCAM and cadherin activity have revealed that the NCAM displays a threshold value of expression for neurite extension, while cadherin shows a graded concentration-dependent activity(41, 42, 43) . Experiments on MAG also support the idea that cell adhesion activity reaches a plateau once above a threshold concentration(44) . These reports indicate that this type of threshold or plateau profile may be a general feature shared by a wide variety of cell adhesion molecules in the Ig superfamily.

We compared the aggregation activity of these gicerin transfectants and found that l-gicerin transfectants were less effective than s-gicerin transfectants. In addition to the degree of aggregation indicated by the score, N(t)/N(0), l-gicerin transfectants did not form as large aggregates as s-gicerin transfectants did (Fig. 8). Experiments assaying neurite extension from ciliary ganglion neurons cultured on a feeder layer of transfectants also showed that s-gicerin transfectants were more effective than l-gicerin transfectants. We could not find any difference in the morphological features of CG neurites such as the number or length of neurites or neurite branches induced by s- or l-gicerin transfectants. These results suggest that a structural change in the cytoplasmic tail of gicerin modulates cell adhesion activity. Of note, neurite extension from rat cerebellar neurons grown on a feeder layer of NCAM 140 transfectants is stronger than that induced by NCAM 180 transfectants that have a larger cytoplasmic tail(45) . Furthermore, our observation that the adhesive activity of l-gicerin toward NOF was less than s-gicerin's supports the idea that the extracellular domain itself possesses cell adhesion activity which is modified by the structure of the cyctoplasmic domain.

Introduction of a frameshift and an insert alters the sequence of the l-gicerin cytoplasmic domain and also leads to deletion of the C-terminal portion of s-gicerin. The protein structure of l-gicerin predicted by the Chou-Fasman method contains foldings which may hide some residues in the cytoplasmic domain. We speculate that one of the following mechanisms underlies the decreased activity of l-gicerin: 1) the l-gicerin-specific C terminus of the cytoplasmic domain blocks a crucial domain for cell adhesion located in the common N terminus half of the cytoplasmic domain found in both gicerins, 2) the tail of l-gicerin lacks a domain present in s-gicerin needed for maximal adhesion activity, or 3) the long tail of l-gicerin modifies the structural conformation of the extracellular domain directly responsible for adhesion. In addition to these intrinsic structural consideration, it is also important to consider potential difference between s- and l-gicerin in interaction with other molecules in the cytoplasm(46, 47) . The large isoform of the most homologous molecule MAG (l-MAG) has a phosphotyrosine in its C terminus thought to interact with Fyn kinase(26) . The deduced amino acid sequences of the l-gicerin cytoplasmic domain shows a weak homology with l-MAG with the tyrosine phosphorylation site conserved. Preliminary data indicate that the tyrosine residue of l-gicerin in gizzard is also phosphorylated. Further studies directed at examining the structural conformation of the tail and its interaction with other proteins may provide important clues to elucidating the mechanisms of adherence and signal transduction mediating gicerin.


FOOTNOTES

*
This work was supported by a grant-in-aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank(TM)/EMBL Data Bank with accession number(s) D49849 [GenBank](l-gicerin).

§
To whom correspondence should be addressed: Dept. of Pharmacology 1, Osaka Universit Medical School, 2-2 Yamadaoka, Suita, Osaka 565, Japan. Tel.: 81-6-879-3521; Fax: 81-6-879-3529.

(^1)
The abbreviations used are: MAG, myelin-associated glycoprotein; NOF, neurite outgrowth factor; RT-PCR, reverse transcription polymerase chain reaction; PAGE, polyacrylamide gel electrophoresis; FCS, fetal calf serum; CG, ciliary ganglion; bp, base pair(s); NCAM, neural cell adhesion molecule.


ACKNOWLEDGEMENTS

We thank Dr. J. Baraban for critical reading of the manuscript and discussion.


REFERENCES

  1. Edelman, G. M. (1986) Annu. Rev. Physiol. 48, 417-430 [CrossRef][Medline] [Order article via Infotrieve]
  2. Reichardt, L. F., and Tomaselli, K. J. (1991) Annu. Rev. Neurosci. 14, 531-570 [CrossRef][Medline] [Order article via Infotrieve]
  3. Salzer, J. M., Holmes, W. P., and Colman, D. R. (1987) J. Cell Biol. 104, 957-965 [Abstract]
  4. Rutishauser, U., Acheson, A., Hall, A. K., Mann, D. M., and Sunshine, J. (1988) Science 240, 53-57 [Medline] [Order article via Infotrieve]
  5. Grenningloh, G., Rehm, E. J., and Goodman, C. S. (1991) Cell 67, 45-57 [Medline] [Order article via Infotrieve]
  6. Rathjen, F. G., Wolff, J. M., Frank, R., Bonhoeffer, F., and Rutishauser, U. (1987) J. Cell Biol. 104, 343-353 [Abstract]
  7. Dodd, J., and Jessell, T. M. (1988) Science 242, 692-699 [Medline] [Order article via Infotrieve]
  8. Harrelson, A. L., and Goodman, C. S. (1988) Science 242, 700-708 [Medline] [Order article via Infotrieve]
  9. Schachner, M. (1991) Neural Recognition Molecules and Their Influence on Cellular Functions , Raven Press, New York
  10. Sonderegger, P., and Rathjen, F. G. (1992) J. Cell Biol. 119, 1387-1394 [Medline] [Order article via Infotrieve]
  11. Mayford, M., Barzilai, A., Kellar, F., Schacher, S., and Kandel, E. R. (1992) Science 256, 638-644 [Medline] [Order article via Infotrieve]
  12. Ramos, R. G. P., Igloi, G. L., Lichte, B., Baumann, U., Maier, D., Schneider, T., Brandstaetter, J. H., Frohlich, A., and Fischbach, K.-F. (1993) Genes & Dev. 7, 2533-2547
  13. Bruemmendorf, T., and Rathjen, F. G. (1993) J. Neurochem. 61, 1207-1219 [Medline] [Order article via Infotrieve]
  14. Snow, P. M., Bieber, A. J., and Goodman, C. S. (1989) Cell 59, 313-323 [Medline] [Order article via Infotrieve]
  15. Kania, A., Han, P.-L., Kim, Y.-T., and Bellen, H. (1993) Neuron 11, 673-687 [Medline] [Order article via Infotrieve]
  16. Burns, F. R., von Kannen, S., Guy, L., Raper, J. A., Kamholz, J., and Chang, S. (1991) Neuron 7, 209-220 [Medline] [Order article via Infotrieve]
  17. Tanaka, H., Matsui, T., Agata, A., Tomura, M., Kubota, I., McFarland, K. C., Kohr, B., Lee, A., Phillips, H. S., and Shelton, D. L. (1991) Neuron 7, 535-545 [Medline] [Order article via Infotrieve]
  18. Arquint, M., Roder, J., Chia, L.-S., Down, J., Wilkinson, D., Bayley, H., Braun, P., and Dunn, R. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 600-604 [Abstract]
  19. Dulac, C., Tropak, M. B., Cameron-Curry, P., Rossier, J., Marshak, D. R., Roder, J., and Le Douarin, N. M. (1992) Neuron 8, 323-334 [CrossRef][Medline] [Order article via Infotrieve]
  20. Gennarini, G., Cibelli, G., Rougon, G., Mattei, M.-G., and Goridis, C. (1989) J. Cell Biol. 109, 775-788 [Abstract]
  21. Hasler, T. H., Rader, C., Stoeckli, E. T., Zuellig, R. A., and Sondergger, P. (1993) Eur. J. Biochem. 211, 329-339 [Abstract]
  22. Moos, M., Tacke, R., Scherer, H., Teplow, D., Frueh, K., and Schachner, M. (1988) Nature 334, 701-703 [CrossRef][Medline] [Order article via Infotrieve]
  23. Cunningham, B. A., Hemperly, J. J., Murray, B. A., Prediger, E. A., Brackenbury, R., and Edelman, G. M. (1987) Science 236, 799-806 [Medline] [Order article via Infotrieve]
  24. Hortsch, M., Bieber, A. J., Patel, N. H., and Goodman, C. S. (1990) Neuron 4, 697-709 [Medline] [Order article via Infotrieve]
  25. Lai, C., Brow, M. A., Nave, K.-A., Noronha, A. B., Quarles, R. H., Bloom, F. E., Milner, R. J., and Sutcliffe, J. G. (1987) Proc. Natl. acad. Sci. U. S. A. 84, 4337-4341 [Abstract]
  26. Umemori, H., Sato, S., Yagi, T., Aizawa, S., and Yamamoto, T. (1994) Nature 367, 572-576 [CrossRef][Medline] [Order article via Infotrieve]
  27. Taira, E., Takaha, N., Taniura, H., Kim, C.-H., and Miki, N. (1994) Neuron 12, 861-872 [Medline] [Order article via Infotrieve]
  28. Hayashi, Y., and Miki, N. (1985) J. Biol. Chem. 260, 14269-14278 [Abstract/Free Full Text]
  29. Taniura, H., Kuo, C.-H., Hayashi, Y., and Miki, N. (1991) J. Cell Biol. 112, 313-322 [Abstract]
  30. Kato, S., Taniura, H., Taira, E., and Miki, N. (1992) Neurosci. Lett. 140, 78-80 [Medline] [Order article via Infotrieve]
  31. Maniatis, T., Fritsch, E. F., and Sambrook, J. (1982) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, New York
  32. Sanger, F., Nicklen, S., and Coulsen, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467 [Abstract]
  33. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159 [CrossRef][Medline] [Order article via Infotrieve]
  34. Posnett, D. N., McGrath, H., and Tam, J. P. (1988) J. Biol. Chem. 263, 1719-1725 [Abstract/Free Full Text]
  35. Tam, J. P. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 5409-5413 [Abstract]
  36. Urushihara, H., Ozaki, H. S., and Takeichi, M. (1979) Dev. Biol. 70, 206-216 [Medline] [Order article via Infotrieve]
  37. Takeichi, M. (1977) J. Cell Biol. 75, 464-474 [Abstract]
  38. Nishi, R., and Berg, D. K. (1979) Nature 277, 232-234 [Medline] [Order article via Infotrieve]
  39. Doherty, P., Rowett, L. H., Moore, S. E., Mann, D. A., and Walsh, F. S. (1991) Neuron 6, 247-258 [Medline] [Order article via Infotrieve]
  40. Goedert, M., Crowther, R. A., and Garner, C. C. (1991) Trends Neurosci. 14, 193-199 [CrossRef][Medline] [Order article via Infotrieve]
  41. Doherty, P., Barton, C. H., Dickson, G., Seaton, P., Rowett, L. H., Moore, S. E., Gower, H. J., and Walsh, F. S. (1989) J. Cell Biol. 109, 789-798 [Abstract]
  42. Doherty, P., Fruns, M., Seaton, P., Dickson, G., Barton, C. H., Sears, T. A., and Walsh, F. S. (1990) Nature 343, 464-466 [CrossRef][Medline] [Order article via Infotrieve]
  43. Doherty, P., and Walsh, F. S. (1991) J. Cell Sci. Suppl. 15, 13-21 [Medline] [Order article via Infotrieve]
  44. Mukhopadhyay, G., Doherty, P., Walsh, F. S., Crocker, P. R., and Filbin, M. T. (1994) Neuron 13, 757-767 [Medline] [Order article via Infotrieve]
  45. Doherty, P., Rimon, G., Mann, D. A., and Walsh, F. S. (1992) J. Neurochem. 58, 2338-2341 [Medline] [Order article via Infotrieve]
  46. Gumbiner, B. M. (1993) Neuron 11, 551-564 [Medline] [Order article via Infotrieve]
  47. Ignelzi, M. A., Jr., Miller, D. R., Soriano, P., and Maness, P. F. (1994) Neuron 12, 873-884 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.